Ironwood Pharmaceuticals | IRWD - Capitale Ordinario





Capitale Ordinario Cambiamento Data
Acadia Pharmaceuticals USD 172.31M 174K 2026-09
Agios Pharmaceuticals USD 59.6M 264K 2026-06
Akebia Therapeutics USD 265.42M 199K 2025-12
Almirall EUR 214.79M 0 2025-12
Alnylam Pharmaceuticals USD 133.88M 141K 2026-09
Amarin USD 20.81M 13K 2025-12
Ardelyx USD 249.15M 2.17M 2026-06
Astellas Pharma JPY 1.79B 109K 2026-09
AstraZeneca USD 1.55B 28K 2026-09
Charles River Laboratories USD 47.88M 148K 2026-09
Coherus Biosciences USD 121.16M 4.92M 2025-12
Emergent BioSolutions USD 100K 0 2023-06
Halozyme Therapeutics USD 114.04M 4.48M 2026-06
Incyte USD 200.98M 1.03M 2026-06
Ironwood Pharmaceuticals USD 160K 0 2024-12
Karyopharm Therapeutics USD 22.54M 4.23M 2026-03
Lexicon Pharmaceuticals USD 363.47M 67K 2025-12
MacroGenics USD 63.65M 86K 2026-06
Moderna USD 391M 2M 2025-09
Myriad Genetics USD 93.5M 400K 2025-12
Pacira USD 39.82M 512K 2026-06
PTC Therapeutics USD 83.33M 445K 2026-06
Puma Biotechnology USD 5K 0 2024-06
Sarepta Therapeutics USD 105.62M 53K 2026-06
Takeda JPY 1.58B 460K 2026-06
Ultragenyx Pharmaceutical USD 98.6M 300K 2026-06
Vanda Pharmaceuticals USD 58K 0 2024-12